foegler – Erbi Biosystems

Press Release

Erbi Biosystems Strengthens Executive Leadership Team with Appointment of Chief Scientific Officer

Press Release

NSF ERC CMaT Welcomes Erbi Biosystems as an Industry Member

Press Release

Innovative US company Erbi Biosystems joins AdBIOPRO as new industrial partner

Press Release

Erbi Biosystems Raises $4M to Provide Small-Scale Perfusion Bioreactors for Development and Manufacture of Cell Therapies

Webinar

“Breez”ing the Way into Process Development with Perfusion Technology

CEO Dr. Michael Chiu provides overview of Erbi Biosystems’ market entrance and future developments.

https://www.genengnews.com/on-your-radar/powering-perfusion-at-the-microscale/

Press Release

Erbi Biosystems raises $3.8M to expand their platform of microfluidic bioprocess and bioreactor equipment, which enables ultra-high cell density and continuous processing

External Articles

Erbi Biosystems Introduces Intensified and Perfusion Microfluidic Bioreactor with Stirred Tank Performance in Just 2 mL Working Volume

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

© 2022 Merck KGaA, Darmstadt Germany and / or its affiliates. All Rights Reserved. MilliporeSigma is the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany.

© 2022, Merck KGaA, Darmstadt Germany and / or its Affiliates. All rights reserved. The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the US and Canada.

X